Comparative Pharmacology
Head-to-head clinical analysis: PAVULON versus TRACRIUM PRESERVATIVE FREE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PAVULON versus TRACRIUM PRESERVATIVE FREE.
PAVULON vs TRACRIUM PRESERVATIVE FREE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Competitive antagonist of nicotinic acetylcholine receptors at the neuromuscular junction, blocking transmission of nerve impulses to skeletal muscle.
Competitive antagonist of nicotinic acetylcholine receptors at the neuromuscular junction, blocking depolarization and preventing muscle contraction.
0.04-0.1 mg/kg IV bolus for intubation; maintenance: 0.01-0.015 mg/kg IV every 25-60 minutes as needed or continuous IV infusion: 1-2 mcg/kg/min.
Initial dose 0.4-0.5 mg/kg IV bolus for intubation; maintenance 0.08-0.1 mg/kg IV every 20-45 minutes as needed or continuous infusion 5-10 mcg/kg/min
None Documented
None Documented
Terminal elimination half-life 100-120 minutes in adults with normal renal function; prolonged in renal impairment.
Terminal elimination half-life: 20-30 minutes (healthy adults). Clinically, recovery is rapid due to redistribution and Hofmann elimination; prolonged in hypothermia or acidosis.
Renal 80-100% as unchanged drug and metabolites; biliary/fecal negligible (<5%).
Renal: 10-20% unchanged; biliary/fecal: 50-60% as metabolites and parent drug; Hofmann elimination (non-enzymatic) accounts for ~45% of clearance.
Category C
Category C
Neuromuscular Blocking Agent
Neuromuscular Blocking Agent